The only anti-VEGF approved to treat four retinal conditions with a single dose strength prefilled syringe, Eylea also is offered in multiple dosing intervals, giving doctors flexibility to address patients’ individual needs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,